VOR
Vor Biopharma Inc
18.70$
+3.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 3.60 | 0.00 | 0.00 | 0.00 | 1.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.62 | 0.26 | 0.28 | 0.26 | 0.26 | 0.25 | 0.13 | 0.34 | – | 0.00 | 0.07 | – | – | |
| -0.62 | -0.26 | -0.28 | -0.26 | -0.26 | -0.25 | -0.13 | -0.34 | – | 0.00 | -0.07 | – | – | |
| 8.17 | 6.16 | 7.15 | 6.39 | 6.37 | 7.38 | 4.28 | 41.75 | 2.12 | 1.94 | 40.91 | 0.48 | 1.42 | |
| 2.28 | 2.13 | 2.35 | 2.11 | 1.96 | 1.74 | 1.06 | 0.38 | 2.16 | 1.70 | 40.77 | 0.40 | 1.30 | |
| 10.45 | 8.02 | 9.23 | 8.24 | 8.33 | 8.86 | 5.33 | 43.79 | 4.21 | 3.64 | 81.68 | 0.88 | 2.71 | |
| -10.45 | -8.29 | -9.50 | -8.50 | -8.33 | -9.11 | -5.33 | -43.79 | -4.21 | -3.64 | -81.75 | -0.88 | -2.71 | |
| – | 0.59 | – | – | – | – | – | – | – | – | – | – | – | |
| -9.82 | -7.74 | -9.06 | -8.15 | -8.05 | -8.94 | -5.21 | -251.24 | -121.63 | 174.52 | -510.53 | -1.16 | 11.56 | |
| 0.42 | 0.17 | 0.26 | 0.26 | – | -0.26 | – | – | – | – | – | – | – | |
| -9.82 | -7.74 | -9.06 | -8.15 | -8.05 | -8.94 | -5.21 | -251.24 | -121.63 | 174.52 | -510.53 | -1.16 | 11.56 | |
| -9.55 | -7.47 | -8.78 | -7.90 | -7.80 | -8.69 | -5.07 | -38.56 | -121.63 | 174.52 | -510.46 | -0.88 | 11.84 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.